280 related articles for article (PubMed ID: 37376140)
1. Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy.
Sulsenti R; Jachetti E
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376140
[TBL] [Abstract][Full Text] [Related]
2. Mast Cell-Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth.
Segura-Villalobos D; Ramírez-Moreno IG; Martínez-Aguilar M; Ibarra-Sánchez A; Muñoz-Bello JO; Anaya-Rubio I; Padilla A; Macías-Silva M; Lizano M; González-Espinosa C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159157
[TBL] [Abstract][Full Text] [Related]
3. The Role of Mast Cells in Molding the Tumor Microenvironment.
Rigoni A; Colombo MP; Pucillo C
Cancer Microenviron; 2015 Dec; 8(3):167-76. PubMed ID: 25194694
[TBL] [Abstract][Full Text] [Related]
4. Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer.
Fereydouni M; Motaghed M; Ahani E; Kafri T; Dellinger K; Metcalfe DD; Kepley CL
Front Oncol; 2022; 12():830199. PubMed ID: 35433433
[TBL] [Abstract][Full Text] [Related]
5. Mast cells: A double-edged sword in cancer.
Derakhshani A; Vahidian F; Alihasanzadeh M; Mokhtarzadeh A; Lotfi Nezhad P; Baradaran B
Immunol Lett; 2019 May; 209():28-35. PubMed ID: 30905824
[TBL] [Abstract][Full Text] [Related]
6. Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy.
Fereydouni M; Ahani E; Desai P; Motaghed M; Dellinger A; Metcalfe DD; Yin Y; Lee SH; Kafri T; Bhatt AP; Dellinger K; Kepley CL
Front Oncol; 2022; 12():871390. PubMed ID: 35574362
[TBL] [Abstract][Full Text] [Related]
7. Controversial role of mast cells in NSCLC tumor progression and angiogenesis.
Longo V; Catino A; Montrone M; Galetta D; Ribatti D
Thorac Cancer; 2022 Nov; 13(21):2929-2934. PubMed ID: 36196487
[TBL] [Abstract][Full Text] [Related]
8. Focus on mast cells in the tumor microenvironment: Current knowledge and future directions.
Shi S; Ye L; Yu X; Jin K; Wu W
Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188845. PubMed ID: 36476563
[TBL] [Abstract][Full Text] [Related]
9. Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers.
Pittoni P; Tripodo C; Piconese S; Mauri G; Parenza M; Rigoni A; Sangaletti S; Colombo MP
Cancer Res; 2011 Sep; 71(18):5987-97. PubMed ID: 21896641
[TBL] [Abstract][Full Text] [Related]
10. Mast Cells as Drivers of Disease and Therapeutic Targets.
Siebenhaar F; Redegeld FA; Bischoff SC; Gibbs BF; Maurer M
Trends Immunol; 2018 Feb; 39(2):151-162. PubMed ID: 29196147
[TBL] [Abstract][Full Text] [Related]
11. Stem cell factor/mast cell/CCL2/monocyte/macrophage axis promotes Coxsackievirus B3 myocarditis and cardiac fibrosis by increasing Ly6C
Luo Y; Zhang H; Yu J; Wei L; Li M; Xu W
Immunology; 2022 Dec; 167(4):590-605. PubMed ID: 36054617
[TBL] [Abstract][Full Text] [Related]
12. Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor Microenvironment.
Teng LKH; Pereira BA; Keerthikumar S; Huang C; Niranjan B; Lee SN; Richards M; Schittenhelm RB; Furic L; Goode DL; Lawrence MG; Taylor RA; Ellem SJ; Risbridger GP; Lister NL
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33799802
[TBL] [Abstract][Full Text] [Related]
13. Role of Mast Cell-Derived Adenosine in Cancer.
Gorzalczany Y; Sagi-Eisenberg R
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137883
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology.
Choi HW; Naskar M; Seo HK; Lee HW
Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829729
[TBL] [Abstract][Full Text] [Related]
15. IL33 and Mast Cells-The Key Regulators of Immune Responses in Gastrointestinal Cancers?
Eissmann MF; Buchert M; Ernst M
Front Immunol; 2020; 11():1389. PubMed ID: 32719677
[TBL] [Abstract][Full Text] [Related]
16. Activation mechanisms and multifaceted effects of mast cells in ischemia reperfusion injury.
He Z; Ma C; Yu T; Song J; Leng J; Gu X; Li J
Exp Cell Res; 2019 Mar; 376(2):227-235. PubMed ID: 30716302
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural features of tumor-associated mast cells in parasympathetic paragangliomas (chemodectomas) of the neck.
Chekmaryova I; Kalinin D; Kostin A; Buchwalow I; Tiemann M; Elieh-Ali-Komi D; Atiakshin D
Microsc Res Tech; 2024 Jun; 87(6):1373-1383. PubMed ID: 38380731
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor-Dependent Signaling.
Johnson C; Huynh V; Hargrove L; Kennedy L; Graf-Eaton A; Owens J; Trzeciakowski JP; Hodges K; DeMorrow S; Han Y; Wong L; Alpini G; Francis H
Am J Pathol; 2016 Jan; 186(1):123-33. PubMed ID: 26597881
[TBL] [Abstract][Full Text] [Related]
19. Single-cell analysis unveils activation of mast cells in colorectal cancer microenvironment.
Xie Z; Niu L; Zheng G; Du K; Dai S; Li R; Dan H; Duan L; Wu H; Ren G; Dou X; Feng F; Zhang J; Zheng J
Cell Biosci; 2023 Nov; 13(1):217. PubMed ID: 38031173
[TBL] [Abstract][Full Text] [Related]
20. Mast cell-T cell axis alters development of colitis-dependent and colitis-independent colorectal tumours: potential for therapeutically targeting via mast cell inhibition.
Sakita JY; Elias-Oliveira J; Carlos D; de Souza Santos E; Almeida LY; Malta TM; Brunaldi MO; Albuquerque S; Araújo Silva CL; Andrade MV; Bonato VLD; Garcia SB; Cunha FQ; Cebinelli GCM; Martins RB; Matthews J; Colli L; Martin FL; Uyemura SA; Kannen V
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36220303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
